Jacc. Cardiovascular Interventions
-
Publication Venue For
-
Impact of Age on the Safety and Efficacy of Ticagrelor Monotherapy in Patients Undergoing PCI..
14:1434-1446.
2021
-
Prosthesis-Patient Mismatch After Aortic Valve Replacement in the PARTNER 2 Trial and Registry..
14:1466-1477.
2021
-
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction..
14:1323-1333.
2021
-
Quo Vadis, Bleeding Risk Models?.
14:1207-1208.
2021
-
Left Ventricular Support for the Management of Cardiogenic Shock: Sooner May Be Better..
14:1120-1122.
2021
-
Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral Approach..
14:907-916.
2021
-
Prospective Evaluation of TMVR for Failed Surgical Annuloplasty Rings: MITRAL Trial Valve-in-Ring Arm 1-Year Outcomes..
14:846-858.
2021
-
Prospective Study of TMVR Using Balloon-Expandable Aortic Transcatheter Valves in MAC: MITRAL Trial 1-Year Outcomes..
14:830-845.
2021
-
The Role for Combined Antithrombotic Therapy With Platelet and Coagulation Inhibition After Lower Extremity Revascularization..
14:796-802.
2021
-
Outcomes of Operator-Directed Sedation and Anesthesiologist Care in the Pediatric/Congenital Catheterization Laboratory: A Study Utilizing Data From the IMPACT Registry..
14:401-413.
2021
-
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis..
14:444-456.
2021
-
Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve Replacement: An STS/ACC TVT Analysis..
14:261-274.
2021
-
Should Interventional Cardiologists Super-Subspecialize?: Moving From Patient Selection to Operator Selection..
14:97-100.
2021
-
Overcoming Obstacles in Designing and Sustaining a High-Quality Cardiovascular Procedure Environment..
13:2806-2810.
2020
-
Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era..
13:2312-2314.
2020
-
Reply: Redo SAVR After Primary TAVR, A Dangerous Sequence?.
13:2186-2187.
2020
-
Limitations of Observational Analyses of Multivessel PCI in Cardiogenic Shock..
13:1836-1837.
2020
-
The Impact of Coronary Physiology on Contemporary Clinical Decision Making..
13:1617-1638.
2020
-
Long-Term Outcomes of Complete Revascularization With Percutaneous Coronary Intervention in Acute Coronary Syndromes..
13:1557-1567.
2020
-
Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database..
13:1515-1525.
2020
-
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement..
13:1484-1488.
2020
-
Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes..
13:1277-1287.
2020
-
Demographics, Procedural Characteristics, and Clinical Outcomes When Cardiogenic Shock Precedes TAVR in the United States..
13:1314-1325.
2020
-
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries..
13:1329-1339.
2020
-
No Increase in All-Cause Mortality at 2 Years Among Patients Undergoing Drug-Coated Balloon Angioplasty..
13:902-904.
2020
-
Evaluating the Diagnostic Performance of Noninvasive Testing and the Perils of Inclusion Bias..
13:656-657.
2020
-
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial..
13:323-331.
2020
-
Racial and Ethnic Differences in Treatment and Outcomes of Severe Aortic Stenosis: A Review..
13:149-156.
2020
-
The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement..
13:219-231.
2020
-
Pre- Versus Post-Procedure Health Care Resource Utilization in Patients Undergoing Commercial Transcatheter Mitral Valve Repair..
12:2416-2426.
2019
-
Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention: An International Consensus Paper..
12:2235-2246.
2019
-
To Double Stick or Not to Double Stick?.
12:2221-2222.
2019
-
Blinded Physiological Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention: The DEFINE PCI Study..
12:1991-2001.
2019
-
Sex Differences in Instantaneous Wave-Free Ratio or Fractional Flow Reserve-Guided Revascularization Strategy..
12:2035-2046.
2019
-
The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial..
12:1985-1987.
2019
-
Advancing Procedural Success in Cardiogenic Shock Among Elderly Patients: How Can We Improve?.
12:1860-1862.
2019
-
Factors Associated With and Outcomes of Aborted Procedures During Elective Transcatheter Aortic Valve Replacement..
12:1768-1777.
2019
-
Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry..
12:1751-1764.
2019
-
Artificial Intelligence and Machine Learning in Cardiology..
12:1312-1314.
2019
-
Institutional Experience With Transcatheter Mitral Valve Repair and Clinical Outcomes: Insights From the TVT Registry..
12:1342-1352.
2019
-
Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry..
12:1140-1149.
2019
-
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry..
12:983-992.
2019
-
Racial Disparities in the Utilization and Outcomes of TAVR: TVT Registry Report..
12:936-948.
2019
-
Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document..
12:805-819.
2019
-
The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
12:569-578.
2019
-
Length of Stay After Transfemoral Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry..
12:422-430.
2019
-
Patient Radiation Dosage During Lower Extremity Endovascular Intervention..
12:473-480.
2019
-
Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement..
12:373-382.
2019
-
Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training..
12:219-228.
2019
-
Reply: Delays From First Medical Contact to Revascularization in Patients With ST-Segment Elevation Myocardial Infarction Presenting With Cardiogenic Shock..
12:107.
2019
-
Predictors and Outcomes of Staged Versus One-Time Multivessel Revascularization in Multivessel Coronary Artery Disease: Insights From the VA CART Program..
11:2265-2273.
2018
-
Preventing Acute Radial Artery Occlusion: A Battle on Multiple Fronts..
11:2251-2253.
2018
-
The Association of Frailty With In-Hospital Bleeding Among Older Adults With Acute Myocardial Infarction: Insights From the ACTION Registry..
11:2287-2296.
2018
-
3-Year Outcomes of the Edwards SAPIEN Transcatheter Heart Valve for Conduit Failure in the Pulmonary Position From the COMPASSION Multicenter Clinical Trial..
11:1920-1929.
2018
-
Performance Goal Criteria for Device Evaluation in Lower Extremity Peripheral Vascular Intervention and the Need for Standardized Data Structure: What Is the Sound of One Hand Clapping?.
11:2004-2006.
2018
-
Association Between Cardiac Catheterization Laboratory Pre-Activation and Reperfusion Timing Metrics and Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Report From the ACTION Registry..
11:1837-1847.
2018
-
Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock..
11:1824-1833.
2018
-
Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry..
11:1746-1756.
2018
-
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 Registry..
11:1710-1718.
2018
-
Safety of the Deferral of Coronary Revascularization on the Basis of Instantaneous Wave-Free Ratio and Fractional Flow Reserve Measurements in Stable Coronary Artery Disease and Acute Coronary Syndromes..
11:1437-1449.
2018
-
Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study..
11:1277-1286.
2018
-
Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document..
11:823-832.
2018
-
Mature Technology for Mature Patients: The Increasing Complexities of Patients Treated With Coronary Angiography and Interventions..
11:889-891.
2018
-
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention..
11:856-864.
2018
-
Should a Meta-Analysis Guide Our Practice?.
11:844-846.
2018
-
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database..
11:665-674.
2018
-
Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry..
11:693-702.
2018
-
Branch Pulmonary Artery Valve Implantation Reduces Pulmonary Regurgitation and Improves Right Ventricular Size/Function in Patients With Large Right Ventricular Outflow Tracts..
11:541-550.
2018
-
Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry..
11:581-589.
2018
-
Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to Action..
11:496-499.
2018
-
Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States..
11:342-350.
2018
-
Contemporary Patterns of Early Coronary Angiography Use in Patients With Non-ST-Segment Elevation Myocardial Infarction in the United States: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry..
11:369-380.
2018
-
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention..
11:181-191.
2018
-
Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts..
11:13-20.
2018
-
Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial..
10:2414-2422.
2017
-
25 Years of Transradial Intervention: Looking Back and Anticipating What Is Ahead..
10:2266-2268.
2017
-
Transfemoral Approach for Coronary Angiography and Intervention: A Collaboration of International Cardiovascular Societies..
10:2269-2279.
2017
-
Variation in the Adoption of Transradial Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry..
10:2242-2254.
2017
-
Chronic Total Occlusion Trials: A Step in the Right Direction..
10:2171-2173.
2017
-
Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study..
10:2017-2025.
2017
-
Death and Dialysis After Transcatheter Aortic Valve Replacement: An Analysis of the STS/ACC TVT Registry..
10:2064-2075.
2017
-
More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor..
10:1659-1661.
2017
-
CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement..
10:1578-1587.
2017
-
Complete Coronary Revascularization: The End Justifies the Means, as Long as Something Justifies the End..
10:1425-1427.
2017
-
Reply: Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement..
10:1278-1279.
2017
-
Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry..
10:1102-1111.
2017
-
The Effect of Clinical Care Location on Clinical Outcomes After Peripheral Vascular Intervention in Medicare Beneficiaries..
10:1161-1171.
2017
-
Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve..
10:810-820.
2017
-
Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR..
10:672-682.
2017
-
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry..
10:645-654.
2017
-
Out-of-Hospital Cardiac Arrest: To CT or Not to CT?.
10:460-461.
2017
-
Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States..
10:342-351.
2017
-
Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study..
10:268-275.
2017
-
Balloon Post-Dilation Following Implantation of a Self-Expanding Transcatheter Aortic Valve Bioprosthesis..
10:168-175.
2017
-
Location, Location, Location..
9:2400-2402.
2016
-
Reply: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention..
9:2459-2460.
2016
-
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States..
9:2376-2386.
2016
-
Cigarette Smoking, Clopidogrel Responsiveness, and Hemoglobin Level..
9:2364.
2016
-
Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry..
9:2189-2199.
2016
-
The Choice Is Reperfusion Therapy: But Which One?.
9:2021-2023.
2016
-
Reply: The Hidden Players..
9:1973.
2016
-
Stuck Between a Clot and a Cold Place: The Specter of Early In-Stent Thrombosis With Therapeutic Hypothermia..
9:1812-1814.
2016
-
Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry..
9:1639-1648.
2016
-
Reply: High-Risk Percutaneous Coronary Interventions: First, Do No Harm..
9:1753-1754.
2016
-
Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial..
9:1694-1702.
2016
-
Chronic Total Coronary Occlusions, Percutaneous Coronary Intervention, and Mortality: A "Hybrid Approach" to Interpretation..
9:1545-1547.
2016
-
The Fuzzy Math of Anticoagulation and Access Site: When 1 + 1 Does Not Always Equal 2..
9:1532-1534.
2016
-
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina..
9:1576-1585.
2016
-
Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials..
9:1419-1434.
2016
-
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents..
9:1461-1469.
2016
-
Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials..
9:1313-1320.
2016
-
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry..
9:1349-1357.
2016
-
Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease..
9:1102-1111.
2016
-
Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Network Meta-Analysis..
9:1036-1046.
2016
-
A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective..
9:871-883.
2016
-
Efficacy of Radial Versus Femoral Access in the Acute Coronary Syndrome: Is It the Operator or the Operation That Matters?.
9:978-979.
2016
-
Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program..
9:884-893.
2016
-
Should the Benefit of Transradial Access Still Be Questioned?.
9:908-910.
2016
-
The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry..
9:771-779.
2016
-
Peripheral Artery Disease Therapies May Perform Differently in Practice Than in Randomized Trials: The Need for Learning Health Systems..
9:725-727.
2016
-
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry..
9:341-351.
2016
-
Benefits and Risks of Extended Dual Antiplatelet Therapy After Everolimus-Eluting Stents..
9:138-147.
2016
-
A Bigger Look Into the "Therapeutic Window" of Platelet Reactivity to Adenosine Diphosphate..
8:1988-1989.
2015
-
The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry..
8:1954-1962.
2015
-
Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study..
8:1880-1889.
2015
-
Proficiency With Vascular Access: Don't Rob Peter to Pay Paul..
8:1865-1867.
2015
-
Transradial Versus Transfemoral Access in Patients Undergoing Rescue Percutaneous Coronary Intervention After Fibrinolytic Therapy..
8:1868-1876.
2015
-
Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?.
8:1647-1656.
2015
-
Effect of Vascular Access Site Choice on Radiation Exposure During Coronary Angiography: The REVERE Trial (Randomized Evaluation of Vascular Entry Site and Radiation Exposure)..
8:1189-1196.
2015
-
Risk Adjusted Mortality Ratings and Public Reporting for High-Risk PCI..
8:1134-1135.
2015
-
6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias..
8:984-990.
2015
-
Approaching the post-femoral era for coronary angiography and intervention..
8:524-526.
2015
-
Radial Versus Femoral Access for Coronary Angiography/Intervention in Women With Acute Coronary Syndromes: Insights From the RIVAL Trial (Radial Vs femorAL access for coronary intervention)..
8:505-512.
2015
-
Reply: Transradial PCI in Women: Zeroing in on Crossovers..
8:639.
2015
-
Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: a systematic review and meta-analysis..
8:436-446.
2015
-
Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial)..
8:324-333.
2015
-
Middle-of-the-night percutaneous coronary intervention and its association with percutaneous coronary intervention outcomes performed the following day: an analysis from the National Cardiovascular Data Registry..
8:49-56.
2015
-
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry..
8:60-69.
2015
-
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials..
8:166-174.
2015
-
The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings..
8:10-16.
2015
-
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial..
7:857-867.
2014
-
Futility, benefit, and transcatheter aortic valve replacement..
7:707-716.
2014
-
Assessing oral beta-blocker therapy after percutaneous coronary intervention for ST-segment elevation myocardial infarction: the role of observational data..
7:602-603.
2014
-
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations..
7:662-673.
2014
-
Uncovering the shroud on antiplatelet therapy for patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention..
7:613-614.
2014
-
Ascending aorta to main pulmonary artery fistula following orthotopic heart transplantation: successful percutaneous closure employing an Amplatzer Duct Occluder..
7:e25-e27.
2014
-
Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy)..
7:266-275.
2014
-
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry..
7:1-9.
2014
-
Anterograde percutaneous coronary-cameral fistula closure employing a guide-in-guide technique..
6:1105-1107.
2013
-
An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry..
6:897-904.
2013
-
Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)..
6:790-799.
2013
-
The value proposition in percutaneous coronary intervention..
6:835-837.
2013
-
P2Y12 Receptor Blockade and Myocardial Perfusion..
6:684-686.
2013
-
Prognostic significance of bleeding location and severity among patients with acute coronary syndromes..
6:709-717.
2013
-
Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial..
6:258-266.
2013
-
Same-day discharge compared with overnight hospitalization after uncomplicated percutaneous coronary intervention: a systematic review and meta-analysis..
6:99-112.
2013
-
Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics..
6:84-89.
2013
-
Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes..
5:1097-1105.
2012
-
Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008..
5:1054-1061.
2012
-
Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy..
5:927-935.
2012
-
Association between periprocedural bleeding and long-term outcomes following percutaneous coronary intervention in older patients..
5:958-965.
2012
-
Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective..
5:790-796.
2012
-
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes..
5:769-776.
2012
-
Contemporary incidence and predictors of stent thrombosis and other major adverse cardiac events in the year after XIENCE V implantation: results from the 8,061-patient XIENCE V United States study..
5:626-635.
2012
-
Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure..
5:416-419.
2012
-
Platelet function measurement in elective percutaneous coronary intervention patients: exploring the concept of a P2Y₁₂ inhibitor therapeutic window..
5:290-292.
2012
-
Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis..
5:131-140.
2012
-
Observations from a transradial registry: our remedies oft in ourselves do lie..
5:44-46.
2012
-
Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry..
5:82-89.
2012
-
A new era of prospective real-world safety evaluation primary report of XIENCE V USA (XIENCE V Everolimus Eluting Coronary Stent System condition-of-approval post-market study)..
4:1298-1309.
2011
-
Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves..
4:1218-1227.
2011
-
Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention..
4:1002-1008.
2011
-
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry..
4:844-850.
2011
-
Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial..
4:769-777.
2011
-
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials..
4:654-664.
2011
-
Autopsy validation study of the academic research consortium stent thrombosis definition..
4:554-559.
2011
-
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)..
4:543-550.
2011
-
The academic research consortium governance charter..
4:595-596.
2011
-
Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations..
4:365-380.
2011
-
Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention..
4:191-197.
2011
-
Survival of patients undergoing rescue percutaneous coronary intervention: development and validation of a predictive tool..
4:42-50.
2011
-
The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes..
3:1209-1219.
2010
-
Rear-view mirror observations on bleeding in acute coronary syndromes..
3:1178-1180.
2010
-
Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines)..
3:1166-1177.
2010
-
Acceptance of high platelet reactivity as a risk factor: now, what do we do about it?.
3:1008-1010.
2010
-
Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry..
3:1068-1073.
2010
-
Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey..
3:1022-1031.
2010
-
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry)..
3:902-910.
2010
-
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry..
3:920-927.
2010
-
Antithrombotic strategy in non-ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the ACTION (Acute Coronary Treatment and Intervention Outcomes Network) Registry..
3:669-677.
2010
-
Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)..
3:419-427.
2010
-
Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial..
3:352-359.
2010
-
Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age..
3:324-331.
2010
-
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention..
3:343-351.
2010
-
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)..
3:203-212.
2010
-
ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies..
3:124-126.
2010
-
Gone but not forgotten: the case for drug-eluting stents in percutaneous revascularization of the chronic coronary total occlusion..
2:1266-1268.
2009
-
Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)..
2:1208-1218.
2009
-
Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)..
2:1178-1187.
2009
-
Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)..
2:1199-1207.
2009
-
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry..
2:1074-1082.
2009
-
The worry about clopidogrel "nonresponsiveness": identification and treatment in the post-percutaneous coronary intervention patient..
2:1102-1104.
2009
-
1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial..
2:909-916.
2009
-
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals..
2:917-924.
2009
-
Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) study..
2:934-943.
2009
-
The impact of place of enrollment and delay to reperfusion on 90-day post-infarction mortality in the ASSENT-4 PCI trial: assessment of the safety and efficacy of a new treatment strategy with percutaneous coronary intervention..
2:925-930.
2009
-
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy..
2:748-757.
2009
-
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry..
2:767-775.
2009
-
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial..
2:624-632.
2009
-
Aortoesophageal fistula after thoracic aortic stent-graft placement: a rare but catastrophic complication of a novel emerging technique..
2:570-576.
2009
-
Accelerating ST-segment elevation myocardial infarction care: emergency medical services take center stage..
2:347-349.
2009
-
Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial..
2:97-106.
2009
-
The role of risk models in upholding standards for percutaneous coronary interventions..
2:144-145.
2009
-
Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention..
2:56-64.
2009
-
In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry..
2:37-45.
2009
-
Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes..
2:17-25.
2009
-
Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial..
1:639-648.
2008
-
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study..
1:511-520.
2008
-
The process of bringing new drug-eluting stents to market will they see the light of day?.
1:533-534.
2008
-
3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial..
1:439-448.
2008
-
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease..
1:369-378.
2008
-
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry..
1:379-386.
2008
-
Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction..
1:129-135.
2008
-
Peri-procedural platelet function and platelet inhibition in percutaneous coronary intervention..
1:111-121.
2008
-
Tardy Pardee: moving medical effectiveness to the forefront..
1:105-107.
2008
-
Direct oral anticoagulants: new drugs and new concepts..
7:1333-1351.
2014
-
Transcatheter Aortic Valve Implant Depth Measurements Differ by Aortography Versus Computed Tomography.
2021
-
The "final" 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent.
2013